Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention-Reference-Cited by-同舟云学术

Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention

Published:2021-04 Issue:7 Volume:14 Page:754-763
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Venetsanos Dimitrios,Skibniewski Mikolaj,Janzon Magnus,Lawesson Sofia S.,Charitakis Emmanouil,Böhm Felix,Henareh Loghman,Andell Pontus,Karlsson Lars O.,Simonsson Moa,Völz Sebastian,Erlinge David,Omerovic Elmir,Alfredsson Joakim

Funder

Bayer

Boston Scientific Corporation

Abbott Laboratories

AstraZeneca

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation;Hansen;Arch Intern Med,2010

3. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial;Dans;Circulation,2013

4. 2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)

5. Management of patients on non-vitamin K antagonist oral anticoagulants in the acute care and periprocedural setting: a scientific statement from the American Heart Association;Raval;Circulation,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uninterrupted direct-acting oral anticoagulation in patients undergoing transradial percutaneous coronary procedures: The DOAC-NOSTOP study rationale and design;Cardiovascular Revascularization Medicine;2024-06

2. Continued non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists during transcatheter aortic valve implantation;EuroIntervention;2023-02

3. Should We Interrupt Oral Anticoagulation Before Percutaneous Coronary Intervention? A National Survey of UK Interventional Cardiologists;Heart, Lung and Circulation;2022-01

4. Correction;JACC: Cardiovascular Interventions;2021-09

5. Peri-interventional Triple Therapy With Dabigatran Improves Vasomotion and Promotes Endothelialization in Porcine Coronary Stenting Model;Frontiers in Cardiovascular Medicine;2021-07-02